TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.70$ -10.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 172 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.1 0.4 239 427 539 344 272 312 315 172
0.1 0.4 232 409 522 332 262 307 310 168
0.1 0.3 105 135 486 183 112 32 46 38
0.1 0.3 229 402 513 325 256 296 295 137
0.5 1.5 0.2 0.2 5.3 13
-1.5 0.4 -0.1
3.2 16 5.5 5.3 4.0
0.2 7.3 359 74 219 222 260 249 286 295
0.1 1.3 20 37 39 40 49 52 45 63
2.4 3.6 2.9 15 15 1.0 0.9
0.0 0.1 2.2 1.0 7.5 3.2 1.5 5.5 2.3 6.0
0.0 6.0 28 172 179 208 197 198 199
-0.1 -6.9 -120 352 321 121 12 63 29 -123
-0.1 -6.9 -154 -334 -578 -812 -1,032 -1,212 -1,269 -1,439
9.2 25 60 55 69 75 1.1 1.9 2.8 2.9

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?